Kolexia
Raverdy Violeta
Médecine générale
Hôpital Huriez
Lille, France
101 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Obésité Obésité morbide Diabète de type 2 Diabète Perte de poids Diabète de type 1 Stéatose hépatique Stéatose hépatique non alcoolique Hypoglycémie

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

A Federated Database for Obesity Research: An IMI-SOPHIA Study.
Life (Basel, Switzerland)   16 février 2024
Performance of non-invasive tests for liver fibrosis and resolution after bariatric surgery.
Metabolism: clinical and experimental   12 janvier 2024
Primary Graft Function and 5 Year Insulin Independence After Pancreas and Islet Transplantation for Type 1 Diabetes: A Retrospective Parallel Cohort Study.
Transplant international : official journal of the European Society for Organ Transplantation   28 décembre 2023
Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort study.
Obesity (Silver Spring, Md.)   27 novembre 2023
Development and validation of an interpretable machine learning-based calculator for predicting 5-year weight trajectories after bariatric surgery: a multinational retrospective cohort SOPHIA study.
The Lancet. Digital health   29 août 2023
Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits.
Nature communications   21 août 2023
Author Correction: Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models.
Nature biotechnology   20 juillet 2023
Oral metformin transiently lowers post-prandial glucose response by reducing the apical expression of sodium-glucose co-transporter 1 in enterocytes.
iScience   25 janvier 2023
Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models.
Nature biotechnology   02 janvier 2023
Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis.
Nature communications   10 septembre 2022